Hot off the Press! New Study Shows that MMS is a Smart Investment in Maternal Health
This article reports new evidence that antenatal multiple micronutrient supplements (MMS) are a highly cost-effective investment in maternal and infant health. Compared with standard iron-folic acid supplements, MMS improves birth outcomes, reduces low birthweight and undernutrition, supports healthier infant growth, and delivers substantial economic returns—estimated at about $37 for every $1 invested.
.png)

